Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)
China flag China · Delayed Price · Currency is CNY
4.130
-0.010 (-0.24%)
Apr 30, 2026, 3:04 PM CST

SHE:300194 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
749.51886.62846.31991.84688.53981.13
Trading Asset Securities
170.12150.05305.0515.2120.86
Cash & Short-Term Investments
919.631,037876.32996.89703.741,002
Cash Growth
-8.84%18.30%-12.10%41.66%-29.77%7.85%
Accounts Receivable
204.98228.37255.39359.39433.24393.02
Other Receivables
9.48.9531.3123.818.9219.66
Receivables
214.38237.33286.71383.19452.16412.68
Inventory
650.86643.05850.97707.8719.75631.92
Other Current Assets
30.0529.5551.738.3651.4238.6
Total Current Assets
1,8151,9472,0662,1261,9272,085
Property, Plant & Equipment
1,6711,7001,7671,7361,6961,446
Long-Term Investments
1,3431,3201,2161,1831,072752.43
Goodwill
132.16132.16261.18261.18485.69508.66
Other Intangible Assets
458.74462.17441.2401.71383.81382.37
Long-Term Deferred Tax Assets
79.4776.7260.5465.81101.8649.15
Long-Term Deferred Charges
119.98118.08105.37138.52176.2170.25
Other Long-Term Assets
14.148.1961.663.3735.35312.58
Total Assets
5,6335,7635,9795,9765,8785,706
Accounts Payable
256.93274.86436.39379.48385.07289.77
Accrued Expenses
12.3839.98116.73225.43253.93232.76
Short-Term Debt
211.51355.42333.32349.11406.34642.15
Current Portion of Long-Term Debt
185.0938.84177.3254.062.51-
Current Portion of Leases
--1.110.980.58-
Current Income Taxes Payable
23.0122.054.4615.526.629
Current Unearned Revenue
33.3222.2754.0951.2561.9657.15
Other Current Liabilities
85.4486.14103.58119.22170.0457.66
Total Current Liabilities
807.67839.571,2271,1951,2871,288
Long-Term Debt
250.62406193.54487.14303.7263.88
Long-Term Leases
0.140.160.491.571.06-
Long-Term Unearned Revenue
105.55108.48109.9192.3698.0675.03
Long-Term Deferred Tax Liabilities
43.7943.7149.551.0964.3535.92
Other Long-Term Liabilities
0.010.010.010.01177.27177.27
Total Liabilities
1,2081,3981,5801,8271,9321,841
Common Stock
1,1901,1901,1901,1901,1901,190
Additional Paid-In Capital
2,2372,2372,2372,2372,2272,227
Retained Earnings
1,001945.98952.26731.91559.53354.92
Comprehensive Income & Other
-3.96-9.0916.74-13.98-31.58-37.96
Total Common Equity
4,4244,3644,3964,1453,9453,734
Minority Interest
1.61.742.253.921.38131.75
Shareholders' Equity
4,4254,3664,3984,1493,9463,866
Total Liabilities & Equity
5,6335,7635,9795,9765,8785,706
Total Debt
647.36800.42705.78892.86714.2906.03
Net Cash (Debt)
272.28236.24170.54104.03-10.4595.96
Net Cash Growth
109.00%38.52%63.93%---68.79%
Net Cash Per Share
0.210.180.150.09-0.010.08
Filing Date Shares Outstanding
1,1891,5701,1901,1901,1901,190
Total Common Shares Outstanding
1,1891,5701,1901,1901,1901,190
Working Capital
1,0071,107838.7931.19640.01796.7
Book Value Per Share
3.722.783.693.483.323.14
Tangible Book Value
3,8333,7693,6933,4823,0762,843
Tangible Book Value Per Share
3.222.403.102.932.592.39
Buildings
--1,2461,191875.88871.16
Machinery
--1,7651,6151,3471,225
Construction In Progress
--114.23155.84695.25441.2
Source: S&P Global Market Intelligence. Standard template. Financial Sources.